Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia

Stroke

Volumn 28, Issue 10, 1997, Pages 2006-2011

  Riepe, Matthias W ^a,b   Kasischke, Karl ^a   Raupach, Anett ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Aspirin; Hippocampus; Hypoxia; Neuroprotection; Rats

Indexed keywords

ACETYLSALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN HYPOXIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 0030711723     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.10.2006     Document Type: Article

References (23)

1. Sivenius J, Laakso M, Penttila IM, Smets P, Lowenthal A, Riekkinen PJ. The European Stroke prevention study: results according to sex. Neurology. 1991;41:1189-1192.
2. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-KB activation. Science. 1996;274:1383-1385.
3. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111.
4. Simon RP, Swan JH, Griffiths T, Meldrum BS. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984;226:850-852.
5. Meldrum B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev. 1990;2:27-57.
6. Nellgard B, Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J Cereb Blood Flow Metab. 1992;12:2-11.
7. Riepe MW, Hori N, Ludolph AC, Carpenter DO. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience. 1995;64:91-97.
8. Riepe M, Niemi WN, Megow D, Ludolph AC, Carpenter DO. Mitochondrial oxidation in rat hippocampus can be preconditioned by selective chemical inhibition of succinic dehydrogenase. Exp Neurol. 1996;138:15-21.
9. Riepe MW, Kasischke K, Gericke CA, Löwe A, Hellweg R. Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor. Neurosci Lett. 1996;211:9-12.
10. Riepe MW, Esclaire F, Kasischke K, Nakase H, Schreiber S, Kempski O, Ludolph AC, Dirnagl U, Hugon J. Increased hypoxic and ischemic tolerance by chemical inhibition of oxidative phosphorylation: 'chemical preconditioning.' J Cereb Blood Flow Metab. 1997;17:257-264.
11. Lutwak-Mann C. The effect of salicylate and cinchophen on enzymes and metabolic processes. Biochem J. 1942;36:706-728.
12. Adams S, Cobb R. A possible basis for the anti-inflammatory activity of salicylates and other non-hormonal anti-rheumatic drugs. Nature. 1958;181:773-774.
13. Whitehouse MW, Haslam JM. Ability of some antirheumatic drugs to uncouple oxidative phosphorylation. Nature. 1962;196: 1323-1324.
14. Martens ME, Lee CP. Reye's syndrome: salicylates and mitochondrial functions. Biochem Pharmacol. 1984;33:2869-2876.
15. Riepe M, Hori N, Ludolph AC, Carpenter DO, Spencer PS, Allen CN. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels. Brain Res. 1992;586:61-66.
16. Kasischke K, Ludolph AC, Riepe MW. NMDA-antagonists reverse increased hypoxic tolerance by preceding chemical hypoxia. Neurosci Lett. 1996;214:175-178.
17. Lee TK, Chen YC, Lien IN, Liu MC, Huang ZS. Inhibitory effect of acetylsalicylic acid on platelet function in patients with completed stroke or reversible ischemic neurologic deficit. Stroke. 1988; 19:566-570.
18. Meng K, Seuter F. Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats. Naunyn-Schmiedebergs Arch Pharmacol. 1977;301:115-119.
19. Vinazzer H, Putter J, Loew D. Influence of intravenously administered acetylsalicylic acid on platelet functions: a pharmacodynamic and pharmacokinetic study. Haemostasis. 1975;4:12-22.
20. 2+ account for poor pyramidal cell structure in hippocampal slices. J Neurochem. 1990;55:473-483.
21. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990;528:21-24.
22. Riepe MW, Ludolph AC, Chemical preconditioning: a cytoprotective therapy. Mol Cell Biochem. 1997;174:249-251.
23. Brody TM. Action of sodium salicylate and related compounds on tissue metabolism in vitro. J Pharmacol Exp Ther. 1956;117: 39-51.